In line with the aim of the EORTC Quality of Life Group (QLG) to “investigate the use of new personal technologies to assess patient’s PRO/ HRQoL in clinical trials, research studies, and routine clinical practice”, this study will position the European Organisation for Research and Treatment of Cancer (EORTC) and QLG in the rapidly evolving field of smart devices in oncology, with potential benefits in relation with the current trends in the pharmaceutical field. More details at the EORTC website.
Principal Investigator
Quality of Life Department, EORTC Headquarters, Brussels, Belgium
Dr. Andrew Bottomley
The project is funded by the EORTC.
Principal Investigators in Geneva
University of Geneva, Switzerland
Prof. Katarzyna Wac, GSEM, CUI, QoL Technologies Lab Director
University of Geneva Hospitals & University of Geneva, Switzerland (forthcoming)
Dre Thanh Lam, MD, Breast Cancer Centre, Geneva University Hospitals, Switzerland